James Healy, Director at Coherus BioSciences, Inc. (CHRS), sold 360,000 shares at $22.05 ($8.0M) on 2019-06-28, disclosed to the SEC on 2019-07-02.
Open-market sale of $8.0M CHRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.05 | 200,000 | $4.4M | 54.9% |
| 2 | $22.61 | 160,000 | $3.6M | 45.1% |
| Total | $22.30 avg | 360,000 | $8.0M | 100% |
| Filing → |
| RAPP | BUY | 2024-06-10 | $9.5M | — | Filing → |
| AVBP | BUY | 2024-01-31 | $8.0M | — | Filing → |
| NTRA | SELL | 2023-12-22 | $37.8M | — | Filing → |